TGF-β receptors and signalling mechanisms

Mineral and Electrolyte Metabolism

Volumn 24, Issue 2-3, 1998, Pages 120-130

  Wrana, Jeffrey L ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

MAD related proteins; Signal transduction; Smad; TGF

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; CELL SURFACE RECEPTOR; LIGAND; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; RECEPTOR; RECEPTOR SUBTYPE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

CARBOXY TERMINAL SEQUENCE; DROSOPHILA; ENZYME ACTIVATION; GENE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL NUCLEUS; GENES, TUMOR SUPPRESSOR; HUMANS; INSECT PROTEINS; MACROMOLECULAR SUBSTANCES; NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

VERTEBRATA;

EID: 0031884680     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057359     Document Type: Review

References (85)

1. Abdollah S, Macías-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL: TβRI phosphorylation of Smad2 on Ser 465 and 467 is required for Smad2/Smad4 complex formation and signalling. J Biol Chem 1997, in press.
2. Arora K, Dai H, Kazuko SG, Jamal J, O'Connor MB, Letsou A, Warrior R: The Drosophila schnurri gene acts in the dpp/TGF-β signaling pathway and encodes a transcription factor homologous to the human MBP family. Cell 1995;81:781-790.
3. Attisano L, Wrana JL: Signal transduction by members of the transforming growth factor-β superfamily. Cytokine Growth Factor Rev 1996;7:327-339.
4. Attisano L, Wrana JL, López-Casillas F, Massagué J: TGF-β receptors and actions. Biochim Biophys Acta 1994;1222:71-80.
5. Attisano L, Wrana JL, Montalvo E, Massagué J: Activation of signalling by the activin receptor complex. Mol Cell Biol 1996;16:1066-1073.
6. Baker JC, Harland R: A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev 1996;10:1880-1889.
7. Brummel T, Twombly V, Marques G, Wrana JL, Newfeld S, Attisano L, Massagué J, O'Connor MB, Gelbart WM: Characterization and relationship of DPP receptors encoded by the saxophone and thick veins genes in Drosophila. Cell 1994;78:251-261.
8. Cárcamo J, Weis FMB, Ventura F, Wieser R, Wrana JL, Attisano L, Massagué J: Type I receptors specify growth inhibitory and transcriptional responses to TGF-β and activin. Mol Cell Biol 1994;14:3810-3821.
9. Chen F, Weinberg RA: Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor β receptor kinases. Proc Natl Acad Sci USA 1995;92: 1565-1569.
10. Chen X, Rubock MJ, Whitman M: A transcriptional partner for MAD proteins in TGF-β signalling. Nature 1996;383:691-696.
11. Chen Y, Lebrun J-J, Vale W: Regulation of transforming growth factor β- and activin-induced transcription by mammalian Mad proteins. Proc Natl Acad Sci USA 1998;93:12992-12997.
12. de Caestecker MP, Hemmati P, Larisch-Bloch S, Ajmera R, Roberts AB, Lechleider RJ: Characterization of functional domains with Smad4/ DPC4. J Biol Chem 1997;272:13690-13696.
13. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, Andrulis I, Thomsen G, Wrana JL, Attisano L: MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996;86:543-552.
14. Eresh S, Riese J, Jackson DB, Bohmann D, Bienz M: A CREB-binding site as a target for decapentaplegic signalling during Drosophila endoderm induction. EMBO J 1997;16:2014-2022.
15. Feng X-H, Derynck R: A kinase subdomain of transforming growth factor-β (TGF-S) type 1 receptor determines the TGF-β intracellular signaling specificity. EMBO J 1997;16:3912-3923.
16. Garrigue-Antar L, Muñoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M: Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res 1995;55: 3982-3987.
17. Gentry LE, Liobin MN, Purchio AF, Marquardt H: Molecular events in the processing of recombinant type I pre-pro-transforming growth factor beta to the mature polypeptide. Mol Cell Biol 1988;8:4162-4168.
18. Graff JM, Bansal A, Melton DA: Xenopus Mad proteins transduce distinct subsets of signals for the TGF-β superfamily. Cell 1996;85:479-487.
19. Grieder NC, Nellen D, Burke R, Basler K, Affolter M: schnurri is required for Drosophila dpp signalling and encodes a zinc finger protein similar to the mammalian transcription factor PRDII-BF1. Cell 1995;81:791-800.
20. Hahn SA, Schutte M, Shamsul Hoque ATM, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE; DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271:350-353.
21. Hata A, Lo RS, Wotton D, Lagna G, Massagué J: Mutations increasing autoinhibition inactive tumour suppressors Smad2 and Smad4. Nature 1997;388:82-87.
22. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu Y-Y, Grinnell BW, Richardson MA, Topper JN, Gimbrone JMA, Wrana JL, Falb D: The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 1997;89:1165-1173.
23. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L, Wrana JL: MAOR1, a MAD-related protein that functions in BMP2 signalling pathways. Cell 1996; 85:489-500.
24. Huang H-C, Murtaugh LC, Vize PD, Whitman M: Identification of a potential regulator of early transcriptional responses to mesoderm inducer in the frog embryo. EMBO J 1995;14:5965-5973.
25. Johnson DW, Berg JN, Baldwin MA, Gallione C, Marondel I, Stenzil T, Speer M, Pericak-Vance M, Qumsiyeh WA, Schwartz C, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous MEM, Marchuk DA: Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-196.
26. Kim J, Johnson K, Chen HJ, Carroll S, Laughon A: Drosophila Mad binds to DNA and directly mediates activation of vestigial by decapentaplegic. Nature 1997;388:304-305.
27. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996;87:159-170.
28. Kretzchmar M, Liu F, Hata A, Doody J, Massagué J: The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 1997; 11:984-995.
29. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J: Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature 1996;383:832-836.
30. Lastres P, Letamendia A, Zhang H, Rius C, Almendro N, Raab U, Lopez LA, Langa C, Fabra A, Letarte M, Bernabéu C: Endoglin modulates cellular responses to TGF-β1. J Cell Biol 1996; 133:1109-1121.
31. Lechleider R, de Caestecker MP, Dehejia A, Polymeropoulos MH, Roberts AB: Serine phosphorylation, chromosomal localization and transforming growth factor-β signal transduction by human bsp-1. J Biol Chem 1996;271: 17617-17620.
32. Letsou A, Arora K, Wrana J, Simin K, Twombly V, Jamal J, Staehling-Hampton K, Hoffmann FM, Gelbart WM, Massagué J, O'Connor MB: Dpp signaling in Drosophila is mediated by the punt gene product: A dual ligand binding type II receptor of the TGF-β receptor family. Cell 1995;80:899-908.
33. Lin HY, Moustakas A, Knaus P, Wells RG, Henis YI, Lodish HF: The soluble exoplasmic domain of the type II transforming growth factor (TGF)-β receptor: A heterogeneously glycosylated protein with high affinity and selectivity for TGF-β ligands. J Biol Chem 1995;270: 2747-2754.
34. Liu F, Hata A, Baker J, Doody J, Cárcamo J, Harland R, Massagué J: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 1996;381:620-623.
35. Liu F, Ventura F, Doody J, Massagué J: Human type II receptor for bone morphogenetic proteins (BMPs): Extension of the two-kinase receptor model to the BMPs. Mold Cell Biol 1995;15:3479-3486.
36. López-Casillas F, Wrana JL, Massagué J: Beta-glycan presents ligand to the TGF-β signaling receptor. Cell 1993;73:1435-1444.
37. Luo K, Lodish JF: Signaling by chimeric erythropoietin-TGF-β receptors: Homodimerization of the cytoplasmic domain of the type I TGF-β receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. EMBO J 1996;15:4485-4496.
38. Luo K, Lodish HF: Positive and negative regulation of type II TGF-β receptor signal tranduction by autophosphorylation on multiple serine residues. EMBO J 1997;16:1970-1981.
39. Macías-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL: MADR2 is a substrate of the TGF-β receptor and its phosphorylation is required for nuclear accumulation and signalling. Cell 1996;87:1215-1224.
40. Markowitz S, Wang J, Myeroff L, Parsons R, Sun LZ, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV: Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-1338.
41. Markowitz SD, Roberts AB: Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 1996;7:93-102.
42. Massagué J, Weis-Garcia F: Serine/threonine kinase receptors: Mediators of transforming growth factor beta family signals; in Pawson T, Parker P (eds): Cancer Surveys Cell Signalling. London, ICRF Press, 1996, pp 41-64.
43. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murell J, McCormick MD, Pericak-Vance MA, Heutink P, Oostra BA, Haitjema T, Westerman CJ, Porteous ME, Guttmacher AE, Letarte M, Marchuck DA: Endoglin, A TGF-β binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type I. Nat Genet 1994;8:345-351.
44. Miyazono K, ten Dijke P, Ichijo H, Heldin C-H: Receptors for transforming growth factor-β. Adv Immunol 1994;55:181-220.
45. Myeroff LL, Parsons R, Kim S-J, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, Bang Y-J, Lee HY, Park J-G, Lynch HT, Roberts AB, Vogelstein B, Markowitz SD: A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 1995;55: 5545-5547.
46. Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S, Shimokata K, Takahashi T, Takahashi T: Somatic in vivo alteration of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 1996;56:2718-2720.
47. Nakao A, Röijer E, Imamura T, Souchelnytskyi S, Stenman G, Heldin C-H, ten Dijke P: Identification of Smad2, a human Mad-related protein in the transforming growth factor β signaling pathway. J Biol Chem 1997;272:2896-2900.
48. Nellen D, Affolter M, Basler K: Receptor ser/thr kinases implicated in the control of Drosophila body pattern by decapentaplegic. Cell 1994;78: 225-237.
49. Newfeld SJ, Chartoff EH, Graff JM, Melton DA, Gelbart WM: Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-β responsive cells. Development 1996;122:2099-2108.
50. Newfeld SJ, Mehra A, Singer MA, Wrana JL, Attisano L: Mothers against dpp participate in a DPP/TGF-β responsive serine-threonine kinase signal transduction cascade. Development 1997;124:3167-3176.
51. Nohno T, Ishikawa T, Saito T, Hosokawa K, Noji S, Wolsing DH, Rosenbaum JS: Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 1995;270: 22522-22526.
52. Nüsslein-Volhard C, Wieschaus E, Kluding H: Mutations affecting the pattern of the larval cuticle in Drosophila melanogaster. I. Zygotic loci on the second chromosome. Rouxs Arch Dev Biol 1984;183:267-282.
53. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB, Sporn MB: Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β. Proc Natl Acad Sci USA 1994; 91:8772-8776.
54. Pece N, Vera S, Cymerman U, White RI Jr, Wrana JL, Letarte M: Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 1997, in press.
55. Penton A, Chen Y, Staehling-Hampton K, Wrana JL, Attisano L, Szidonya J, Cassill A, Massagué J, Hoffmann FM: Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell 1994;78:239-250.
56. Raftery LA, Twombly V, Wharton K, Gelbart WM: Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophi-la. Genetics 1995;139:241-254.
57. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B: MAD-related genes in the human. Nat Genet 1996;13:347-349.
58. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB: New class of transforming growth factors potentiated by epidermal growth factor. Proc Natl Acad Sci USA 1981;78:5339-5343.
59. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, Miyazono K: Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 1995;92: 7632-7636.
60. Ruberte E, Marty T, Nellen D, Affolter M, Basler K: An absolute requirement for both the type II and type I receptors, punt and thick veins for dpp signalling in vivo. Cell 1995;80:889-897.
61. Rustgi AK: MAD about colorectal cancer. Gastroenterology 1996;111:1387-1389.
62. Saitoh M, Nishitoh H, Amagasa T, Miyazono K, Takagi M, Ichijo H: Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-β. J Biol Chem 1996;271:2769-2775.
63. Savage C, Das P, Finelli A, Townsend S, Sun C, Baird S, Padgett R: Caenorhabditis elegans genes sma-2, sma-3 and sma-4 define a conserved family of transforming growth factor β pathway components. Proc Natl Acad Sci USA 1996;93:790-794.
64. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM: Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 1995;139:1347-1358.
65. Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP: A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 1997; 388:87-93.
66. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K: TAB1: an activator of the TAKI MAPKKK in TGF-β signal transduction. Science 1996;272:1179-1182.
67. Souchelnytskyi S, ten Dijke P, Miyazono K, Heldin C-H: Phosphorylation of Serl 65 in TGF-β type I receptor modulates TGF-β1-induced cellular responses. EMBOJ 1996;15:6231-6240.
68. Staehling-Hampton K, Laughon AS, Hoffmann FM: A Drosophila protein related to the human zinc-finger transcription factor PRDII/MBPI/ HIV-EP1 is required for dpp signaling. Development 1995;121:3393-3403.
69. Takagi Y, Kohmura H, Futamura M, Kida H, Tanemura H, Shimokawa K, Saji S: Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 1996;111: 1369-1372.
70. Ten Dijke P, Miyazono K, Heldin C-H: Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Opin Cell Biol 1996;8:139-145.
71. Thomsen GH: Xenopus Mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP2/4 receptor. Development 1996;122:2359-2366.
72. Topper JN, Cai J, Qui Y, Anderson KR, Xu Y, Deeds J, Feeley R, Wolf B, Gimeno C, Sampson BA, et al: Vascular MADs: Two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci USA 1997, in press.
73. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y, Matsuzawa Y: High levels of transforming growth factor β in patients with colorectal cancer: Association with disease progression. Gastroenterology 1996;110:375-382.
74. Weeks DL, Melton DA: A maternal mRNA localized to the vegetal hemisphere in Xenopus eggs codes for a growth factor related to TGF-β. Cell 1987;51:861-867.
75. Wiersdorff V, Lecuit T, Cohen SM, Mlodzik M: Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signalling and propagation of morphogenesis in the Drosophila eye. Development 1996;122:2153-2162.
76. Wieser R, Attisano L, Wrana JL, Massagué J: Signalling activity of TGF-β type II receptors lacking specific domains in the cytoplasmic region. Mol Cell Biol 1993;13:7239-7247.
77. Wieser R, Wrana JL, Massague J: GS domain mutations that constitutively activate TβR-I, the downstream signalling component in the TGF-β receptor complex. EMBO J 1995;14: 2199-2208.
78. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang X-F, Massagué J: TGF-β signals through a heteromeric protein kinase receptor complex. Cell 1992;71:1003-1014.
79. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J: Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-347.
80. Wu R-Y, Zhang Y, Feng X-H, Derynck R: Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol 1997;17:2521-2528.
81. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K: Identification of a member of the MAPKKK family as a potential mediator of the TGF-β signal transduction. Science 1995; 270:2008-2011.
82. Yamashita H, ten Dijke P, Huylebroeck D, Sampath TK, Andries M, Smith JC, Heldin C-H, Miyazono K: Osteogenic protein-1 binds to activin type II receptor and induces certain activin-like effects. J Cell Biol 1995;130:217-226.
83. Yingling JM, Das P, Savage C, Zhang M, Padgett RW, Wang X-F: Mammalian Dwarfins are phosphorylated in response to TGF-β and are implicated in control of cell growth. Proc Natl Acad Sci USA 1996;93:8940-8944.
84. Zhang Y, Feng X-H, Wu R-Y, Derynck R: Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 1996; 383:168-172.
85. Zhang Y, Musci T, Derynck R: The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr Biol 1997;7:270-276.